Location
Switzerland, Europe
Check Size
$100K - $5M
Investment Stage
Seed
Series A
Focus Areas
BioTech
Pharmaceuticals
About Investor
Martin Münchbach is a Managing Partner and Founding Partner at Pureos Bioventures, targeting investments in Pharmaceuticals, BioTech, and Therapeutics sectors at seed and Series A stages with investment ranges from $100K to $5.0M. Münchbach has been a venture capital investor since 1999, specializing in life science companies across all stages and types, and leads a fund that exclusively invests in private innovative drug development companies with an emphasis on next-generation biological drugs.
Previous investments
Ariceum Therapeutics
25M |2023
27M |2022
Radius Health
66M |2011
15M |2008
58M |2007
Tioga Pharmaceuticals
24M |2006
Similar Investors
JG
Joaquin Gomez
United Kingdom, Europe
$50K - $1M
Pre Seed
,Seed
,WT
William Tunstall-Pedoe
United Kingdom, Europe
$10K - $500K
Pre Seed
,Seed
,CJ
Christoph Janz
Germany, Europe
$580K - $3.5M
Pre Seed
,Seed
,IT
Igor Tikhturov
United Kingdom, Europe
$100K - $5M
Pre Seed
,Seed
,EV
Eze Vidra
United Kingdom, Europe
$300K - $1.5M
Pre Seed
,Seed
,PL
Pierre-Eric Leibovici
France, Europe
$500K - $10M
Seed
,Series A
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP